At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
Oxytocin +1 moredrug
Likely dose
Misoprostol 25 mcgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Cervical Ripening for Induction of Labor: Misoprostol Versus Oxytocin in Conjunction With Foley Balloon
In Brief
A clinical study evaluating Oxytocin and Misoprostol for Induction of Labor. Completed, enrolled 50 participants across 1 site.
Detailed Summary
The purpose of this study is to specifically investigate the efficacy of an alternative pharmacologic cervical ripening agent, misoprostol, versus the standard oxytocin, as an adjunct to Foley balloon for induction of the unfavorable cervix.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInduction of Labor
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2009
Primary CompletionMar 2010
First PostedJun 2010
TodayJul 2026
First PostedJun 9, 2010
Enrollment StartSep 1, 2009
Primary CompletionMar 1, 2010
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 16.1 years ago
Interventions
Oxytocindrug
Foley balloon placement with intravenous low dose oxytocin administration starting 2 milliunits per minute.
Misoprostoldrug
Misoprostol, 25 mcg, is placed intravaginally into the posterior fornix of the vagina in conjunction with Foley balloon placement